Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: Silver Bullet Data continues rise and IOG loses more than one-third of its value

AIM movers: Silver Bullet Data improvement and Ocean Harvest delays

AIM movers: Potential Barkby disposal and Sportech dropping London quote

Music copyrights opportunities

Aquis weekly movers: Ora Technology continues rise

AIM weekly movers: Infrastructure India selling main asset

Burford Capital potential billion dollar payout

AIM movers: Drilling in Angola for Corcel and AMTE Power rescue fundraising

Direct Line sells commercial insurance business

AIM movers: Angle extends life of cash pile and CVS investigated by CMA

AIM movers: Light Science Technologies enhancing purchase and Global Invacom leaving

Strip Tinning set to win electric vehicle contracts

New AIM admission: Tribe Technologies mines market

AIM movers: Molecular Energies selling Argentinian oil interests and GetBusy reinvests cash

AIM movers: Ergomed bid and further delay of 600 Group accounts

Aquis weekly movers: Valereum set to complete Gibraltar Stock Exchange purchase

AIM weekly movers: Pantheon Resources contingent resources report

AIM movers: boohoo stakebuilding and Libertine delays

Revolution Beauty appoints new boss

AIM movers: Harland & Wolff’s positive judgement and ex-dividends

Rosslyn Data Technologies raising cash to help it move to profitability

Lack of liquidity leads to share price rise for RegTech Open Project

AIM movers: Instem recommends bid and Challenger Energy secures funding

Star Energy’s Croatian geothermal investment

AIM movers: Quadrise reassures investors and Pelatro set to leave AIM

New standard listing: RegTech Open Project looks fully valued

Aquis weekly movers: Inteliqo generates initial revenues

AIM weekly movers: Plexus Holdings set to multiply revenues this year

Watches of Switzerland slumps on Rolex acquisition

AIM movers: Panthera Resources litigation funding and Proteome Sciences falls into loss

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020